SX-7
Natural health product licensed in Canada
- Licence holder
- Iovate Health Sciences International Inc.
- NPN or DIN-HM
- 80051471
- Status
- Active licence
- Licence date
- 5 June 2014
- Revision date
- 7 November 2014
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Myristica fragrans Houtt.: L'huile essentielle de cette plante est interdite.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 1,3,7-Triméthylxanthine Source : Caféine | 160 mg | Not calculated |
| Coffea canephora Source : Graine(s) Extraction ratio : 9:1 Dry plant equivalent : 1,800 mg Potency : 45 % Chlorogenic Acids | 200 mg | Not calculated |
| Coffea canephora Source : Graine(s) Potency : 2 % Caffeine | Not specified | Not calculated |
| Coffea canephora Source : Graine(s) Potency : 5 % Chlorogenic Acids | 200 mg | Not calculated |
| Niacine | 8 mg | Not calculated |
| Myristica fragrans Source : Graine(s) Extraction ratio : 5:1 Dry plant equivalent : 500 mg | 100 mg | Not calculated |
| Salvia officinalis Source : Feuille | 50 mg | Not calculated |
| [5R-(5alpha,9beta,11E)]-5-Amino-11-ethylidene-5,6,9,10-tetrahydro-7-methyl-5,9-methanocycloocta[b]pyridin-2(1H)-one Source : Huperzia serrata - plante entière | 13 mcg | Not calculated |
| Punica granatum Source : Punica granatum, Fruit | 50 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Gélatine, Dioxyde de silicium, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps the body to metabolize carbohydrates. Helps the body to metabolize fats. Helps the body to metabolize proteins. The following is for occasional use only: Helps temporarily to promote alertness and wakefulness, and to enhance cognitive performance. Helps temporarily to relieve fatigue, to promote endurance and enhance motor performance. Helps to temporarily increase thermogenesis and basal metabolic rate.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80051471
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed. Photograph the packaging